Stifel Maintains Buy on Staar Surgical, Lowers Price Target to $44
Portfolio Pulse from Benzinga Newsdesk
Stifel analyst Thomas Stephan maintains a Buy rating on Staar Surgical (NASDAQ:STAA) but lowers the price target from $50 to $44.

August 26, 2024 | 3:57 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Stifel analyst Thomas Stephan maintains a Buy rating on Staar Surgical but lowers the price target from $50 to $44, indicating a positive outlook with some caution.
The maintenance of a Buy rating suggests continued confidence in Staar Surgical's prospects, but the lowered price target indicates some caution about future performance. This mixed signal may result in a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100